Bruce G. Allen Investments’s Vertex Pharmaceuticals VRTX Stock Holding History

Bruce G. Allen Investments’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.45K	Buy	15 +8	+114%	+$3.54K	﹤0.01%	522
2026 Q1	$3.13K	Hold	7	–	–	﹤0.01%	635
2025 Q4	$3.17K	Hold	7	–	–	﹤0.01%	628
2025 Q3	$2.74K	Hold	7	–	–	﹤0.01%	647
2025 Q2	$3.12K	Sell	7 -5	-42%	-$2.3K	﹤0.01%	632
2025 Q1	$5.82K	Hold	12	–	–	﹤0.01%	539
2024 Q4	$4.83K	Hold	12	–	–	﹤0.01%	580
2024 Q3	$5.58K	Hold	12	–	–	﹤0.01%	559
2024 Q2	$5.63K	Hold	12	–	–	﹤0.01%	550
2024 Q1	$5.02K	Sell	12 -3	-20%	-$1.27K	﹤0.01%	587
2023 Q4	$6.1K	Buy	+15	New	+$5.54K	0.01%	561

Other funds holding VRTX

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Bruce G. Allen Investments's VRTX Position: Q2 2026 in Review

Bruce G. Allen Investments increased its Vertex Pharmaceuticals (VRTX) stake by 114% in Q2 2026, buying an estimated $3.54K and bringing the position to 15 shares worth $7.45K. The position accounts for ﹤0.01% of the portfolio, ranked #522.

Bruce G. Allen Investments first reported a position in VRTX in Q4 2023 and has held it in 11 quarters since. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

Bruce G. Allen Investments held 15 shares of Vertex Pharmaceuticals worth $7.45K as of Q2 2026.
Bruce G. Allen Investments bought 8 Vertex Pharmaceuticals shares in Q2 2026, an estimated $3.54K.
Vertex Pharmaceuticals made up ﹤0.01% of Bruce G. Allen Investments's portfolio in Q2 2026, its #522 holding.
Bruce G. Allen Investments first reported a position in Vertex Pharmaceuticals in Q4 2023 and has held it in 11 quarters since.
1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Bruce G. Allen Investments's 13F filing for Q2 2026, filed 31 Jul 2026.